Anti-Sm faces a threat to its reigning position as the marker antibody
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Jearn, La-He | - |
dc.contributor.author | Kim, Think-You | - |
dc.date.accessioned | 2022-07-16T22:34:49Z | - |
dc.date.available | 2022-07-16T22:34:49Z | - |
dc.date.created | 2021-05-12 | - |
dc.date.issued | 2011 | - |
dc.identifier.issn | 0172-8172 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/hanyang/handle/2021.sw.hanyang/169421 | - |
dc.language | 영어 | - |
dc.language.iso | en | - |
dc.publisher | SPRINGER HEIDELBERG | - |
dc.title | Anti-Sm faces a threat to its reigning position as the marker antibody | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | Jearn, La-He | - |
dc.identifier.doi | 10.1007/s00296-010-1537-8 | - |
dc.identifier.scopusid | 2-s2.0-79961168388 | - |
dc.identifier.wosid | 000293024300024 | - |
dc.identifier.bibliographicCitation | RHEUMATOLOGY INTERNATIONAL, v.31, pp.1119 - 1120 | - |
dc.relation.isPartOf | RHEUMATOLOGY INTERNATIONAL | - |
dc.citation.title | RHEUMATOLOGY INTERNATIONAL | - |
dc.citation.volume | 31 | - |
dc.citation.startPage | 1119 | - |
dc.citation.endPage | 1120 | - |
dc.type.rims | ART | - |
dc.type.docType | Letter | - |
dc.description.journalClass | 1 | - |
dc.description.isOpenAccess | N | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.relation.journalResearchArea | Rheumatology | - |
dc.relation.journalWebOfScienceCategory | Rheumatology | - |
dc.subject.keywordPlus | SYSTEMIC-LUPUS-ERYTHEMATOSUS | - |
dc.identifier.url | https://link.springer.com/article/10.1007%2Fs00296-010-1537-8 | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
222, Wangsimni-ro, Seongdong-gu, Seoul, 04763, Korea+82-2-2220-1365
COPYRIGHT © 2021 HANYANG UNIVERSITY.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.